rts logo

Hims & Hers Health Inc (HIMS) Is Now En Route to Higher Prices

Hims & Hers Health Inc (NYSE: HIMS) is 68.43% higher on its value in year-to-date trading and has touched a low of $5.65 and a high of $17.16 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HIMS stock was last observed hovering at around $15.66 in the last trading session, with the day’s loss setting it -0.67%.

Currently trading at $14.99, the stock is -1.59% and 25.06% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.82 million and changing -4.28% at the moment leaves the stock 72.22% off its SMA200. HIMS registered 51.26% gain for a year compared to 6-month gain of 138.31%. The firm has a 50-day simple moving average (SMA 50) of $3.44 and a 200-day simple moving average (SMA200) of -$150.50.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 14.25% loss in the last 1 month and extending the period to 3 months gives it a 68.43%, and is -8.09% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.60% over the week and 5.78% over the month.

Hims & Hers Health Inc (HIMS) has around 1046 employees, a market worth around $3.21B and $872.00M in sales. Fwd P/E is 34.38. Profit margin for the company is -2.70%. Distance from 52-week low is 165.31% and -12.65% from its 52-week high. The company has generated returns on investments over the last 12 months (-6.68%).

Hims & Hers Health Inc quarterly earnings per share for the current quarter are estimated at $0.01 with sales reaching $270.5M over the same period.The EPS is expected to grow by 204.85% this year, but quarterly earnings will post 35.70% year-over-year. Quarterly sales are estimated to grow 41.80% in year-over-year returns.

Hims & Hers Health Inc (HIMS) Top Institutional Holders

277 institutions hold shares in Hims & Hers Health Inc (HIMS), with institutional investors hold 70.05% of the company’s shares. The shares outstanding are 205.10M, and float is at 138.71M with Short Float at 9.20%. Institutions hold 61.81% of the Float.

The top institutional shareholder in the company is Vanguard Group Inc with over 13.7 million shares valued at $128.76 million. The investor’s holdings represent 6.76% of the HIMS Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 9.93 million shares valued at $93.33 million to account for 4.90% of the shares outstanding. The other top investors are Institutional Venture Management XV, LLC which holds 7.71 million shares representing 3.80% and valued at over $72.47 million, while Institutional Venture Management XVI, LLC holds 3.80% of the shares totaling 7.71 million with a market value of $72.47 million.

Hims & Hers Health Inc (HIMS) Insider Activity

The most recent transaction is an insider sale by Boughton Soleil,the company’sChief Legal Officer. SEC filings show that Boughton Soleil sold 2,503 shares of the company’s common stock on Apr 01 ’24 at a price of $15.65 per share for a total of $39172.0. Following the sale, the insider now owns 0.17 million shares.

Hims & Hers Health Inc disclosed in a document filed with the SEC on Mar 20 ’24 that Dudum Andrew (Chief Executive Officer) sold a total of 50,361 shares of the company’s common stock. The trade occurred on Mar 20 ’24 and was made at $16.34 per share for $0.82 million. Following the transaction, the insider now directly holds 0.0 shares of the HIMS stock.

Still, SEC filings show that on Mar 20 ’24, Okupe Oluyemi (Chief Financial Officer) disposed off 9,912 shares at an average price of $15.82 for $0.16 million. The insider now directly holds 168,627 shares of Hims & Hers Health Inc (HIMS).

Related Posts